[EN] QUINAZOLINONES AS PROLYL HYDROXYLASE INHIBITORS<br/>[FR] QUINAZOLINONES EN TANT QU'INHIBITEURS DE PROLYLE HYDROXYLASE
                        
                            
                                申请人:JANSSEN PHARMACEUTICA NV
                            
                            
                                公开号:WO2010093727A1
                            
                            
                                公开(公告)日:2010-08-19
                            
                            Quinazolinone compounds of formula (I) are described, which are useful as prolyl hydroxylase inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity. Thus, the compounds may be administered to treat, e.g., anemia, vascular disorders, metabolic disorders, and wound healing.